<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The content of A1, A2, and E <z:chebi fb="0" ids="39015">apolipoproteins</z:chebi> in blood plasma of males (40-59 years of age) with normo-, hyper-, and <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> was determined by rocket immunoelectrophoresis </plain></SENT>
<SENT sid="1" pm="."><plain>Considerable changes were revealed in the <z:chebi fb="0" ids="47775">alphalipoprotein cholesterol</z:chebi>/A1-apo ratio which were evidence of increased capacity of HDLP for transporting cholesterol in <z:e sem="disease" ids="C0342883" disease_type="Disease or Syndrome" abbrv="">hyperalphalipoproteinemia</z:e> and a decrease in this HDLP function in <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> irrespective of their concentration in blood plasma </plain></SENT>
<SENT sid="2" pm="."><plain>A reverse correlative connection was revealed between the A1-apo content and the E-apo content in dysalphalipoproteinemia </plain></SENT>
<SENT sid="3" pm="."><plain>It is suggested that the changes in the content of A1-apo and E-apo in blood plasma are significant in <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism in dysalphalipoproteinemia </plain></SENT>
</text></document>